Malaria

New study provides molecular-level understanding of common antimalarial drugs

Published in TB and Outbreaks Week, December 10th, 2002

TransForm Pharmaceuticals, Inc., has announced a new understanding of the connection between the physical chemistry and mechanism of action of quinoline-based drugs used to treat malaria.

These findings can be applied to further discovery and design of research that may overcome the problem of drug resistance that has developed to the malaria parasite.

The study, conducted in collaboration with the Weizmann Institute in Israel, and published in the November/December 2002 issue of Crystal Growth and Design, provides new insights on how a better understanding of the physical chemistry, associated with some diseases, can be used to develop new...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2002-12-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry